Peel Therapeutics

Peel Therapeutics, founded in Salt Lake City, is a clinical-stage biotech company dedicated to improving patient lives through innovative drug development. The company's core mission is to harness the power of evolutionary biology to treat and prevent diseases, initially inspired by cancer-fighting proteins found in elephants. Peel Therapeutics focuses on creating novel therapeutics that leverage nature's solutions, aiming to address unmet medical needs in oncology and other disease areas.

Notable figures affiliated with Peel Therapeutics include leading scientists and researchers who specialize in evolutionary biology and clinical applications. The company has attracted significant investment from venture capital firms and industry stakeholders committed to advancing biotech innovations. Key achievements include successful preclinical studies and the initiation of clinical trials, positioning Peel Therapeutics as a promising player in the biotech industry. Their work has the potential to make a substantial impact on modern medicine by introducing groundbreaking treatments derived from nature's evolutionary adaptations.